Carcinoma, Neuroendocrine
"Carcinoma, Neuroendocrine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)
MeSH Number(s)
C04.557.465.625.650.240
C04.557.470.200.025.370
C04.557.580.625.650.240
Concept/Terms
Carcinoma, Neuroendocrine- Carcinoma, Neuroendocrine
- Carcinomas, Neuroendocrine
- Neuroendocrine Carcinoma
- Neuroendocrine Carcinomas
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Neuroendocrine".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Neuroendocrine".
This graph shows the total number of publications written about "Carcinoma, Neuroendocrine" by people in Harvard Catalyst Profiles by year, and whether "Carcinoma, Neuroendocrine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 1 | 2 |
| 2004 | 2 | 0 | 2 |
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 2 | 4 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 2 | 3 |
| 2011 | 3 | 6 | 9 |
| 2012 | 2 | 4 | 6 |
| 2013 | 3 | 4 | 7 |
| 2014 | 2 | 3 | 5 |
| 2015 | 6 | 3 | 9 |
| 2016 | 4 | 0 | 4 |
| 2017 | 3 | 3 | 6 |
| 2018 | 9 | 1 | 10 |
| 2019 | 21 | 1 | 22 |
| 2020 | 13 | 0 | 13 |
| 2021 | 26 | 0 | 26 |
| 2022 | 14 | 3 | 17 |
| 2023 | 12 | 0 | 12 |
| 2024 | 6 | 0 | 6 |
Below are the most recent publications written about "Carcinoma, Neuroendocrine" by people in Profiles.
-
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E. JCO Precis Oncol. 2024 Apr; 8:e2300454.
-
Initial surgical management of sporadic medullary thyroid cancer: Guidelines based optimal care - A systematic review. Clin Endocrinol (Oxf). 2024 May; 100(5):468-476.
-
Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small. Oncologist. 2024 Mar 04; 29(3):185-189.
-
Cytologic risk stratification of medullary thyroid carcinoma: Does it make the grade? Cancer Cytopathol. 2024 Apr; 132(4):209-211.
-
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma. Histopathology. 2024 May; 84(6):947-959.
-
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study. Thyroid. 2024 01; 34(1):26-40.
-
Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma. Lung Cancer. 2024 02; 188:107454.
-
Improved survival for stage IV sinonasal small cell neuroendocrine carcinoma treated with chemotherapy and anti-PD-L1 therapy. BMJ Case Rep. 2023 Nov 17; 16(11).
-
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study. Thyroid. 2024 Feb; 34(2):167-176.
-
PAX1 expression in thymic epithelial neoplasms and morphologic mimics. Hum Pathol. 2023 Dec; 142:7-14.